New research revealed that manufacturer-funded clinical trials deem drugs more effective than non-sponsored trials.

Structural analysis of the herpes simplex virus polymerase revealed that mutations affecting its drug binding and flexibility may drive treatment resistance.

Profiling over 100,000 genomes, researchers identified rare mutations associated with early menopause and cancer, and that some mutations pass down to children.

A new mouse study suggests that folinic acid treatment could help the immune system penetrate pancreatic cancer’s protective shell.

A new technique boosts the sensitivity of mass cytometry to allow detection and characterization of low-abundance markers, yielding new disease insights.